Difluoromescaline
pharmaceutical compound
Difluoromescaline (DFM), also known as 4-difluoromethoxy-3,5-dimethoxyphenethylamine, is a psychedelic drug of the phenethylamine and scaline families related to mescaline. It is a difluorinated derivative of mescaline.
The drug's dose range is 50 to 100 mg orally and its duration is 12 to 18 hours. It is about 3- or 4-fold more potent than mescaline and has a longer duration in comparison. The drug is said to produce strong psychedelic effects.
Difluoromescaline interacts with serotonin receptors and acts as a low-potency full agonist of the serotonin 5-HT2A receptor.
It was first described in the scientific literature by Daniel Trachsel in 2012. The drug's pharmacology was studied in more detail in 2021. It is not a controlled substance in Canada as of 2025.
This brief starts where responsible research should: with the source description of “Difluoromescaline” as pharmaceutical compound. Everything that follows is an evidence route, not borrowed authority.
Why this record matters
The subject matters to the general reference register because the source frames it as pharmaceutical compound. Its deeper value depends on whether names, dates, institutions and citations support that framing.
The citation trail is more important than the brevity of the summary: it shows where individual claims can be examined in context. The source revision retrieved here is dated Jun 17, 2026. The linked authority identifier is Q136679039. None of the 0 selected statements returned an explicit reference. The first chronological checks are 2012, 2021 and 2025.
Overview language is designed for orientation and should not be treated as a substitute for the evidence cited beneath it. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “Difluoromescaline”, its source revision and the description used here.
- Expand the search: follow Difluoromescaline primary sources, Difluoromescaline archive and Difluoromescaline research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Difluoromescaline”?
- Which institution is responsible for the underlying evidence?
- Which cited source is closest to the event, object or claim?
Search terms from this dossier
This entry incorporates text from “Difluoromescaline” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.